Sign in

CIK 0001661053

  • Non-accelerated filer
  • Smaller reporting company

enVVeno Medical Corp

Sign in to watch
Ticker
NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330936180
Phone
+1 949-261-2900
Business address
70 DOPPLER, IRVINE, CA, 92618
Former names
Hancock Jaffe Laboratories, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$123
in 1 filing, $123 under 10b5-1 plans

Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duhay Francis −$123 Director sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2025-12-16 Glickman Marc H. SVP & Chief Medical Officer Other disposition · Restricted Stock Units −100,000 0
2024-12-18 Glickman Marc H. SVP & Chief Medical Officer Grant or award · Stock Options +75,000 75,000
2023-12-05 Glickman Marc H. SVP & Chief Medical Officer Grant or award · Stock Options +100,000 100,000
2021-11-30 Glickman Marc H. SVP & Chief Medical Officer Grant or award +100,000 101,600
2021-11-30 Glickman Marc H. SVP & Chief Medical Officer Grant or award · Stock Options +265,700 265,700
2021-05-21 Glickman Marc H. SVP & Chief Medical Officer Purchase +1,600 $5.90 $9K 1,600
2021-02-18 Glickman Marc H. SVP & CMO Grant or award · Stock Option +406,000 406,000
2020-07-18 Glickman Marc H. SVP & CMO Grant or award · Stock Option +1,000,000 1,000,000
2019-07-26 Glickman Marc H. CMO and Senior Vice President Returned to the company · Stock Option (Right to Buy) −184,500 0
2019-07-26 Glickman Marc H. CMO and Senior Vice President Grant or award · Stock Option (Right to Buy) +184,500 184,500
2019-07-26 Glickman Marc H. CMO and Senior Vice President Grant or award · Stock Option (Right to Buy) +180,000 180,000

Page 1 of 1 · 11 trades